Device type · LZG
Pump, Infusion, Insulin
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LZG
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
16
510(k), De Novo and PMA
Adverse event reports
10,593
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Pump, Infusion, Insulin
- Product code
- LZG
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 880.5725
- FDA record
- Classification database entry for LZG
Latest FDA decisions
The 8 newest of 16 since 2015.
K262153 · Decided Sep 2, 2026 · 68 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K253534 · Decided Apr 8, 2026 · 146 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K240158 · Decided Sep 4, 2024 · 229 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K241622 · Decided Jul 2, 2024 · 27 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K223372 · Decided Apr 24, 2023 · 171 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
- Extended Reservoir510(k)
K210714 · Decided Apr 6, 2022 · 392 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K211575 · Decided Aug 13, 2021 · 84 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
K192659 · Decided Oct 21, 2019 · 26 days after receipt
Device type: Pump, Infusion, Insulin (LZG) · Hospital Medicine & Nursing
Reports received
10,593
Received Nov 1, 2025 to Nov 19, 2026. Includes 29 of another or unstated type.
Malfunction reports
9,957
94% of reports
Injury reports
600
5.7% of reports
Death reports
7
0.1% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1,375 | 111 | 0 | 0 |
| Jan 24 | 1,489 | 133 | 0 | 1 |
| Feb 24 | 1,356 | 111 | 0 | 0 |
| Mar 24 | 1,426 | 105 | 1 | 0 |
| Apr 24 | 1,397 | 92 | 0 | 0 |
| May 24 | 1,531 | 121 | 0 | 0 |
| Jun 24 | 1,144 | 99 | 0 | 0 |
| Jul 24 | 1,914 | 133 | 1 | 0 |
| Aug 24 | 1,520 | 93 | 0 | 0 |
| Sep 24 | 1,561 | 82 | 0 | 0 |
| Oct 24 | 1,440 | 114 | 0 | 0 |
| Nov 24 | 1,068 | 81 | 1 | 0 |
| Dec 24 | 1,128 | 86 | 0 | 0 |
| Jan 25 | 1,150 | 111 | 2 | 0 |
| Feb 25 | 789 | 61 | 0 | 0 |
| Mar 25 | 1,143 | 63 | 2 | 0 |
| Apr 25 | 861 | 72 | 0 | 0 |
| May 25 | 845 | 49 | 1 | 0 |
| Jun 25 | 929 | 41 | 0 | 0 |
| Jul 25 | 976 | 59 | 0 | 0 |
| Aug 25 | 717 | 51 | 0 | 0 |
| Sep 25 | 1,105 | 72 | 0 | 0 |
| Oct 25 | 1,241 | 59 | 0 | 0 |
| Nov 25 | 801 | 42 | 1 | 0 |
| Dec 25 | 867 | 41 | 0 | 0 |
| Jan 26 | 828 | 25 | 0 | 0 |
| Feb 26 | 683 | 34 | 1 | 0 |
| Mar 26 | 826 | 50 | 0 | 0 |
| Apr 26 | 790 | 38 | 1 | 0 |
| May 26 | 711 | 37 | 1 | 0 |
| Jun 26 | 990 | 85 | 0 | 0 |
| Jul 26 | 988 | 101 | 2 | 9 |
| Aug 26 | 829 | 52 | 0 | 7 |
| Sep 26 | 948 | 63 | 0 | 3 |
| Oct 26 | 696 | 32 | 1 | 10 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Unintended Movement2,050
- Loss of or Failure to Bond1,837
- Obstruction of Flow1,601
- Mechanical Problem1,043
- Fluid/Blood Leak1,013
- Material Twisted/Bent981
- Insufficient Device Problem Information752
- Activation, Positioning or Separation Problem740
- Failure to Fire687
- Difficult to Insert440
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions5,979
- Hyperglycemia4,360
- Hemorrhage/Blood Loss/Bleeding262
- Elevated Ketones/ Diabetic Ketoacidosis148
- Erythema144
- Pain139
- Vomiting133
- Skin Inflammation/ Irritation110
- Swelling/ Edema90
- Hypoglycemia71
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2604-2026 · Started May 20, 2026 · Posted by FDA Jun 30, 2026
Reason given: External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may...
Cause as FDA categorized it: Process design
Z-2605-2026 · Started May 20, 2026 · Posted by FDA Jun 30, 2026
Reason given: External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may...
Cause as FDA categorized it: Process design
- Paradigm Insulin Pump (MMT-712, MMT-715)Open, Classified
Z-1748-2026 · Started Feb 13, 2026 · Posted by FDA Apr 2, 2026
Reason given: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and...
Cause as FDA categorized it: Device Design
- Paradigm REF: MMT-712 and MMT-715Open, Classified
Z-1255-2025 · Started Jan 31, 2025 · Posted by FDA Mar 3, 2025
Reason given: All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can...
Cause as FDA categorized it: Device Design
Z-0154-2023 · Started Oct 17, 2022 · Posted by FDA Nov 15, 2022
Reason given: The firm has become aware of PDM battery issues, including battery swelling, fluid leaking from the battery, and extreme overheating, which may pose a fire hazard. The firm has received a complaint alleging fire as a result of thermal energy from a DASH PDM.
Cause as FDA categorized it: Device Design
- Accu-Chek Aviva Plus Test Strip, Blood Glucose Monitoring System, Model numbers: 06908152001, 06908217001, 06908268001, 06908349001, 06908373001Open, Classified
Z-2351-2021 · Started Jul 28, 2021
Reason given: Test strip vials may open while inside sealed cartons during shipment. An open vial might expose the test strips to humidity, which might damage the strips and result in inaccurate results, potentially leading to inappropriate therapy decisions and adverse health consequences.
Cause as FDA categorized it: Package design/selection
Z-1203-2021 · Started Feb 1, 2021
Reason given: Certain foreign user guides include a misprint which could lead to an incorrect bolus delivery and hypoglycemia. Only Outside the US (OUS): Error in the Omnipod DASH User Guide text, page 6 of the User Guide, the text states that the comma (,) is not used for the decimal on the PDM, when in fact it is the period (.)...
Cause as FDA categorized it: Labeling design
Z-2164-2020 · Started Apr 2, 2020
Reason given: After the device has been in use for about 2 months, data processing in the PDM can be slowed such that the Bolus Calculator fails to accurately subtract the correct amout of IOB before suggesting a bolus amount.
Cause as FDA categorized it: Device Design
Showing the 8 newest of 126 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.